Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis

Ann Intern Med. 2022 Apr;175(4):600-601. doi: 10.7326/M22-0057. Epub 2022 Feb 1.

Authors

David R Holtgrave¹, Ronald O Valdiserri²

Affiliations

¹ School of Public Health, University at Albany, State University of New York, Albany, New York.
² Rollins School of Public Health, Emory University, Atlanta, Georgia.

PMID: 35099987
DOI: 10.7326/M22-0057

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
HIV Infections* / prevention & control
Humans
Pre-Exposure Prophylaxis*

Substances

Anti-HIV Agents